Why a pharma company needs SOC
NIS2 requires continuous cybersecurity monitoring. But for pharma, SOC is not just compliance — it is protection of drug production, clinical trial data, and supply chain. A pharmaceutical company without SOC is a company unaware of an ongoing attack until ransomware encrypts the production line. Without a SOC, detecting an attack often takes many months. With SOC: under 24 hours. Given the value of pharmaceutical data, this difference means millions of USD.
SOC specifics for pharma
OT monitoring alongside IT
A pharmaceutical SOC must monitor not only corporate networks but also production control systems (SCADA/DCS), LIMS/ELN systems, and environmental monitoring.
GMP context
SOC analysts must understand which systems are under GMP validation and how to escalate incidents affecting production data integrity.
Clinical data protection
Monitoring access to EDC systems, detecting research data exfiltration, alerting on investigator behavior anomalies.
Compliance-aware response
Response procedures accounting for reporting obligations: NIS2 (24h/72h), GDPR (72h), GMP (immediately to QA).
Internal SOC vs SOC as a Service
Internal SOC — full control, deep process knowledge. Cost: high (a dedicated team, SIEM, tools). Justified for multinationals with multiple sites.
SOC as a Service — faster start (about 2 weeks on the nFlo onboarding schedule), lower cost (a monthly subscription), access to experts and threat intelligence. Ideal for mid-size pharma companies.
Hybrid model — internal L1/L2 for OT monitoring (requires production process knowledge), external L3 and threat hunting. Best option for large companies with manufacturing.
4-phase SOC implementation plan
Phase 1: Preparation (month 1-2)
- Inventory of systems to monitor (IT, OT, LIMS, EDC)
- Define pharma-specific use cases
- Select model (internal/external/hybrid)
Phase 2: Technical deployment (month 3-5)
- Deploy SIEM with log collectors
- Integrate sources: AD, firewalls, EDR, OT systems, LIMS
- Configure pharma-specific correlation rules
Phase 3: Operationalization (month 6-8)
- Rule tuning, false positive reduction
- Develop IR playbooks for pharma scenarios
- Integrate with GMP processes (QA notification)
Phase 4: Maturation (month 9-12)
- Proactive threat hunting
- Purple team exercises
- Metrics and reporting for management and regulators
Cybersecurity for Your Industry
Learn more about cybersecurity in your industry:
Best practices for implementation
Effective implementation requires several key steps:
- Risk assessment and inventory — identify assets, threats, and vulnerabilities specific to your organization.
- Policy development — document requirements, roles, and responsibilities.
- Technical controls — deploy tools and configurations proportionate to identified risks.
- Training and awareness — engage employees in protecting organizational security.
- Monitoring and continuous improvement — regularly verify effectiveness and adapt to the evolving threat landscape.
GMP changes what response is allowed to do
In most industries containment is a technical decision. In a validated pharmaceutical environment it is a regulated one: systems that touch production or quality data are validated, and a change to them — including a patch, a configuration change, or an agent installation — goes through a documented change control before it may be applied. An incident does not suspend that requirement.
So the response plan has to be written with the quality function, not around it: which actions are pre-approved as emergency changes, who signs them, and what documentation the change produces afterwards. Where that agreement is missing, the security team finds itself holding a containment action it is not permitted to execute. Building the security programme so that it fits alongside validation rather than against it is part of an ISMS audit and advisory engagement in this sector.
Related topics
See also:
- NIS2 for hospitals — implementation and funding
- Security Audit Pricing Calculator
- NIS2 for hospitals — compliance
Related services and products
- ISMS Review, Audit and Advisory
- BCMS Audit and Advisory
- Bitdefender GravityZone Integrity Monitoring
